NEW | N-Nitrosamine Mini-Event

Date: 14 June 2022

Time: 13.00 (BST), 14.00 (CEST), 8.00 (EST) - 17.30 (BST)

This NEW free to attend webinar / Hopin mini-event seeks to present the very latest in terms of N Nitrosamines, tracking the evolution of the issue through the regulations as well as looking at specific risk factors and the scientific investigations currently being undertaken to both better understand and contextualise the range of potential risk factors. Trying, where possible, to tease out what is risk and what is not.  In parallel it simultaneously looked at the latest advances in technology to support both research and risk assessment.

Using the Hopin Virtual Platform, you will be able to attend the main plenary lecture, participate in the hosted discussion session on specialist topics and visit our sponsors / exhibitors for face-to-face video meetings.

Who should attend?

Chemists / Analysts, Quality Assurance professionals, Regulatory Affairs, Directors / VPs with overall accountability

The Key Note Presentation:  will be presented by Dr Andrew Teasdale, AstraZeneca.

“N-Nitrosamines – Current status of regulations and science”

Outline Program:

1.00       Event Opens – Visit the Sponsors / Exhibitors

2.00       Plenary Session / Key Note Speaker –  Dr Andrew Teasdale, Chair of AstraZeneca Impurities Advisory Group and Head of External Advocacy

3.30      Hosted Discussion Session – Lhasa  |  How can nitrosamine risk assessments be supported by in silico systems and data sharing initiatives?

4.00       Hosted Discussion Session – Waters

4.30       Hosted Discussion Session – ACD Labs  |  Using CMC Decision Support to Enhance Control Strategies

4.15      Visit the Sponsors / Exhibitors

5.30       End

We’d like to thank Lhasa, Waters and ACD Labs for their kind sponsorship.

This Hopin event will also allow participants to interact directly with sponsors to understand more about the tools and systems that they are able to offer that are key to the effective management and control of N-Nitrosamines.

About our Speaker:

Dr Andrew Teasdale is the author of over 50 pier reviewed scientific papers as well as three books:

  • ICH Quality Guidelines: An Implementation Guide,
  • Genotoxic Impurities: Strategies for Identification and Control (published originally in 2010, followed now by a much revised second edition:
  • Mutagenic Impurities: Strategies for Identification and Control, published February 2022.

Andrew is also tutor on the 2-day course: Practical Management of Impurities and Development of Effective and Comprehensive Control Strategies.


Book Now
Gold Sponsor